CAS Number 1235403-62-9 ChemSpider 29411106 ChEMBL CHEMBL2325014 | PubChem CID 46840946 UNII 25U4N985O2 | |
 | ||
Legal status | ||
PF-05089771 is a selective, small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker under development by Pfizer as a novel analgesic. As of June 2014, it has completed phase II clinical trials for wisdom tooth removal and primary erythromelalgia.
References
PF-05089771 Wikipedia(Text) CC BY-SA